Video slideshow on antibody development services

1. Define Your Goal,
Let MBS Create the Strategy

2. Your Partner in Antibody Development
The central focus of MBS’s experienced
technical team is understanding
customer goals and developing
strategies to achieve success, even for
the most complex projects.
For over 25 years, antibody
development has been the
core competency of Maine
Biotechnology Services.

3. Expert Project Management
The key to a successful and timely
antibody development is a goal-focused
plan. MBS offers comprehensive project
planning and management.
• Antigen analysis and sourcing
• Recombinant production capabilities
• Evaluation of reagents, strategies, and timelines
• Project plan delivered to the customer

4. Monoclonal Antibody Development
• 28 Day immunization protocol
• Early, refined clone selection
• Fit-for-purpose screening
• Technical support at every phase
MBS brings expertise, creativity
and flexibility to developing a
strategy for any antibody
development project.

5. Polyclonal Antibody Development
Polyclonal Antibody Development
is offered as a stand alone service
or as a compliment to a larger
monoclonal or assay development
goal set.
• Rabbits, goats, sheep, and llamas
• Large or small scale
• Custom purification plans

6. Antibody Production and Purification
MBS offers seamless transition
from antibody development into
production, saving time and cost.
• In vitro or In vivo
• cGMP certified productions
• Customizable schedules
• Wide range of purification services

7. Assay Services
Let MBS fill the gap between hybridoma
screening and final antibody selections
with your assay in mind.
• Specificity
• Sensitivity
• Matched pair characterization
• Matrix compatibility

8. Antibody Products
The MBS expertise, process, and
high quality standard have been
applied to the development of a
well supported catalog of
antibodies to meet our
customer’s clinical diagnostic
needs

9. Most Comprehensive Norovirus Panel
on the Market

10. Chikungunya Virus and an Expanding
Arbovirus Offering
Currently offering 3 monoclonal antibodies
specific to Chikungunya virus. Shown to
recognize active virus with no cross reactivity to
other viruses of concern.
MBS is currently launching a
new development project to
develop antibodies specific for
NS1 of both Dengue Fever and
Zika Virus. It is our goal to offer
comprehensive panels of
differentiating antibodies to
these increasingly concerning
targets.

11. No Substitute for Experience
MBS delivers on a complete
partnership. Wholly owned and
operated in Maine, USA; we welcome
the opportunity to discuss your next
antibody development.